The price you pay for Tremfya (guselkumab) may depend on factors such as the form you use and whether you have health insurance. Financial assistance may be available to help you with the cost of ...

The Tremfya (trem-FYE-ah) ad starts with a woman in a dark room with patches of her skin seemingly on fire. Another woman ...

Tremfya is being positioned as a successor to $9 billion-a-year blockbuster Stelara – which is due to start losing patent protection next year in the US and 2024 in Europe – but while it is ...

The FDA has approved a label extension for Johnson & Johnson’s Tremfya (guselkumab) in psoriatic arthritis, the first drug from the IL-23 class to gain a foothold in this indication.

Tremfya, an IL-23 inhibitor, is currently approved by the FDA for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis. More on Johnson & Johnson ...

The easy-to-hold design of the Tremfya One-Press makes it painless for everyone to use. Tremfya® (guselkumab) is an FDA-approved treatment for adults with active psoriatic arthritis (PsA) or moderate ...

Plus, patients’ desire to embrace newer therapies could help channel potential Stelara losses into prescriptions for newer immunology therapies, including J&J’s own Tremfya, company executives ...